Skip to main content
Are you a healthcare professional?Join GLP1Zoom for HCPs →
GLP1ZoomFind provider

GLP1Zoom Medical Review

Medical Reviewer

Specialties

endocrinologyobesity medicine

Licensed in: CA

Articles by GLP1Zoom Medical Review

Bariatric Surgery vs GLP-1 vs Both: 2026 Decision Guide

Surgeons and obesity-medicine doctors increasingly combine bariatric procedures with GLP-1s, before or after surgery. We compare percent total weight loss, durability, costs, and who benefits from each path.

GLP-1, Birth Control, and Pregnancy: The Washout Rules

GLP-1 medications have specific contraception and pregnancy planning requirements most prescribers rush through. We cover the Wegovy washout, Mounjaro's oral contraceptive warning, and breastfeeding gaps.

Vegan and Vegetarian Eating on GLP-1: Protein Playbook

GLP-1 medications cut appetite so dramatically that plant-based eaters routinely fall short on protein. Here is how to hit 1.2-1.6 g/kg with tofu, tempeh, seitan, and legumes when nothing sounds good.

Semaglutide Microdosing: Low-Dose Protocols, Risks, Reality

Microdosing semaglutide has exploded on Reddit and TikTok as a tolerability and cost hack. We cover what off-label means here, pharmacokinetic concerns, and questions to bring to your prescriber.

GLP-1 Shortage Status in 2026: What Is Available Now

The FDA officially resolved the GLP-1 shortage in 2025, but regional availability still varies. Here is the current FDA shortage list status and what pharmacists report on the ground in 2026.

How to Inject a GLP-1 Pen: Sites, Rotation, and Common Mistakes

Most GLP-1 prescriptions ship with a pen and a leaflet but limited coaching. Here is a plain-language walkthrough of injection sites, rotation, and the mistakes that cause bruising.

Saxenda vs Wegovy: Daily vs Weekly GLP-1 Injection

Saxenda was the original GLP-1 weight-loss injection but Wegovy replaced it for most patients. Here is when liraglutide may still be the right molecule and how the two compare on trial data.

Mounjaro vs Zepbound: Same Drug, Different Indication

Mounjaro and Zepbound contain identical tirzepatide but are FDA-approved for different conditions. Here is what that means for insurance, pricing, and prescriber decisions.

Tirzepatide vs Semaglutide: Mechanism, Results, and Side Effects

Tirzepatide and semaglutide are the two dominant GLP-1 classes but work differently. Here is what SURMOUNT, STEP, and SURPASS data show about efficacy and tolerability.

Cash Pay vs Compounded GLP-1: Which Is Cheaper in 2026?

After the FDA shortage ended, branded self-pay prices dropped while compounded options narrowed. Here is the cost math between LillyDirect, NovoCare, and remaining compounded routes.

GLP-1 Manufacturer Savings Cards in 2026: Eligibility and Limits

Savings cards advertise $25 monthly prices, but eligibility carve-outs exclude most patients. Here is what each manufacturer card actually covers in 2026.

Sulfur Burps on GLP-1: Why They Happen and How to Reduce Them

Sulfur burps are one of the most viral GLP-1 complaints on TikTok and Reddit. Here is the digestive mechanism behind the rotten-egg smell, why delayed gastric emptying makes it worse, and the dietary patterns associated with relief.

GLP-1 Hair Loss: Why It Happens and What Helps

Hair shedding is one of the most-searched GLP-1 side effects, but it is rarely caused by the drug itself. Here is the mechanism, the timeline, and what dermatologists tell patients.

GLP-1 Side Effects Week by Week: A 12-Week Timeline

Most GLP-1 side effects follow a predictable arc tied to dose escalation. Here is what patients commonly report each week and when symptoms typically peak.

How to Switch from Ozempic to Wegovy: A Patient Guide

Both Ozempic and Wegovy are semaglutide, but FDA-approved for different conditions. Here is exactly how to switch — clinically, administratively, and practically.

Wegovy Cost Without Insurance: A 2026 Guide

Wegovy retails near $1,349/month without insurance. But several legitimate channels reduce the cost to $200-400/month. Here is a complete breakdown of your options in 2026.

Compounded Semaglutide in 2026: What the FDA Crackdown Means for You

In March 2026, the FDA sent warning letters to dozens of telehealth providers marketing compounded GLP-1 medications. This explainer covers what changed, why, and what your options are now.

Ozempic Face: Causes, Prevention, and How to Manage

"Ozempic face" refers to facial volume loss seen in some patients during GLP-1 weight loss. It is not a side effect of the drug itself, but a consequence of rapid fat loss. Here is what to know.

GLP-1 Weight Loss Timeline: Realistic Results Month by Month

Clinical trial data shows where you are likely to be at each stage of GLP-1 weight loss treatment. Here is a month-by-month timeline of realistic expectations.